CD8A and neoplasm: We then analysed the effects of Y27632 on tumour growth in the CT26.CL25 tumour model in which CD4+ or CD8+ T cells were depleted by intraperitoneal injection of a neutralizing antibody (Supplementary Figs. 6e and 10).